Bruker-Alicona InfiniteFocus Microscope System Software Upgrade
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA), specifically the National Forensic Chemistry Center (NFCC), is soliciting quotes for a Bruker-Alicona InfiniteFocus Microscope System Software Upgrade. This Firm Fixed Price (FFP) Purchase Order is a total-small business set-aside aimed at enhancing forensic analysis capabilities in Cincinnati, OH. Quotes are due June 30, 2026.
Scope of Work
This opportunity requires a comprehensive software upgrade for the existing Bruker-Alicona IFM G5 Systems. Key deliverables include:
- Software Licenses: Alicona Control Server, Analysis Software, Offline MetMaX (Unlimited), and Analysis Searchability Software.
- Functionality: Native compatibility with IFM G5 formats, terabyte-scale indexing with "Search-in-Place," non-destructive data integrity, and seamless dataset ingestion.
- Hardware Requirements: Minimum specifications include Windows 11 64-bit, NVidia GPU, 16GB RAM, and a 1TB Hard Disk.
- Services: FCC IT Server and Client Installation, system installation, and training.
- Support: Annual maintenance for all licenses, phone and online remote support, and updated system files. The upgrade will improve searchability and comparison of 3D datasets, increasing forensic analysis efficiency and supporting counterfeit drug investigations.
Contract & Timeline
- Contract Type: Firm Fixed Price (FFP) Purchase Order.
- Period of Performance: One (1) twelve-month base year, with potential for option years.
- Set-Aside: Total Small Business.
- Questions Due: June 22, 2026, by 1:00 PM Washington DC Local Time.
- Quotes Due: June 30, 2026, by 1:00 PM Washington DC Local Time.
- Published: June 15, 2026.
- Place of Performance: Cincinnati, OH.
Evaluation
Award will be made based on the Lowest Price Technically Acceptable (LPTA) evaluation method. Quotations must meet or exceed all specified technical requirements.
Additional Notes
Quotes must be submitted via email to Tiffany Gates (tiffany.gates@fda.hhs.gov). Vendors must be authorized resellers and/or servicing agents. All electronic documents must be submitted without macros. Security and privacy requirements are detailed in the solicitation.